Hyderabad, India, March 27, 2017 -- The report “Biomarkers Market: Types (Biomarkers: Disease & related, Imaging, Others) Application (Drug Discovery, Bioinformatics, Others) Therapeutic Areas (Cardiology, Neurology, Others) Products (Hormones, Enzymes, Others) End Users (Hospitals, Others)-Forecast (2017-2022)”, published by IndustryARC, estimates that rising demand for personalized medicine, usefulness in drug development and increased investment in research and development will propel the market significantly in North America.
Browse numerous 20 Market Tables and 50 Figures spread through 85 Pages and an in-depth TOC on “Biomarkers Market 2017-2022”
http://industryarc.com/Report/9593/global-biomarkers-market.html
Scope & Regional Forecast of the Biomarkers Market:
Biomarkers are measurable characteristics of an organism that reflect a particular physiological state. They are biological molecules which act as indicators of a particular disease or treatment condition and measured in biological samples such as blood, urine, and saliva. Biomarkers are used to predict the severity of a disease, assess the effectiveness of a therapy, measure the drug response rate and detect adverse drug reactions. They also aid in the development of new drug therapies and can also be used to assess the functioning of the internal organs while providing assistance to clinicians in decision making.
Request Sample PDF Brochure @ http://industryarc.com/pdfdownload.php?id=9593
The high cost associated with the discovery and development, a time consumed and the stringent regulations are few of the challenges of this industry. The industry is growing at a rapid pace due to the increased adoption of biomarkers. In the future biomarkers will not just be used for the detection, prevention, and treatment of cancers but also other diseases. The prime factor for the development of the biomarkers market is the advancement in technology such as genome sequencing.
Inquiry before buying report @ http://industryarc.com/inquiry-before-buying.php?id=9593
Prominent Segmentations Involved in the Biomarkers Market:
The Biomarkers Market can be broken down into various segmentations on the basis of -
- Type: Disease-related biomarkers (Diagnostic biomarker, Prognostic biomarker), Drug-related biomarkers, Imaging biomarkers, Molecular biomarkers, Surrogate biomarkers and others.
- Applications: Drug discovery & Development, Molecular diagnostics, Genetic studies, Clinical Trials, Bioinformatics and Others.
- Therapeutic areas: Oncology, Cardiology, Immunology, Neurology and Others.
- Products: Hormones, Enzymes, Antibodies, Gene products and others.
- End Users: Pharmaceutical Companies, Hospitals, Research Institutes, CROs and Diagnostic Labs.
- Geographic Location: Americas, Europe, Asia-Pacific and Rest of the world.
Some of the sample companies profiled in the Biomarkers Market report are as follows:
- Enzo Biochem
- EKF Diagnostics Holdings plc.
- PerkinElmer, Inc.
- Bio-Rad Laboratories
- Roche Diagnostic Limited
- Siemens Healthcare
- Abbott Laboratories Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies Inc.
- G.E. Healthcare Inc.
Why buy this report?
- Get a detailed picture of the Biomarkers Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase Biomarkers Market Report @ http://industryarc.com/purchasereport.php?id=9593
Browse Related Reports:
Synthetic Biology Market: By Tool (XNAS, Chassis Organisms) By Technology (Bioinformatics, DNA sequencing, integrated systems) By Products (Core products, Enabled Products) By Application (Agriculture, Food, Biofuel, Medicine)-Forecast (2016- 2021)
http://industryarc.com/Report/15142/synthetic-biology-market.html
Genomics Market: Product Types (DNA Microarrays, Sequencers, PCR); Services (Bioinformatics, DNA Sample Sequencing, De Novo, SNPS, Gene Expression) and Geography - Forecast (2017-2022)
http://industryarc.com/Report/1275/genomics-market-analysis-and-forecast-report.html
About IndustryARC:
IndustryARC is a research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.
We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Media Contact
Mr. Sanjay Matthews
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc
Know more about IndustryARC Events: http://industryarc.com/events.php


Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 



